Search

Your search keyword '"D. Neil Hayes"' showing total 383 results

Search Constraints

Start Over You searched for: Author "D. Neil Hayes" Remove constraint Author: "D. Neil Hayes"
383 results on '"D. Neil Hayes"'

Search Results

1. Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study

2. Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype

3. Salivary Duct Carcinoma with Rhabdoid Features of the Parotid Gland with No E-Cadherin Expression: A Report with Anti-HER2 Therapy and Review of the Literature

4. Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234

5. Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma

6. Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer

7. Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer

8. SCISSOR: a framework for identifying structural changes in RNA transcripts

9. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

10. Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway

11. Integrated Molecular Characterization of Testicular Germ Cell Tumors

12. Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking

13. The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma

14. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

15. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

16. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

17. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

18. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

19. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

20. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

21. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

22. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

23. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

24. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

25. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

26. Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes.

27. Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes.

28. Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck

30. NFE2L2Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

31. A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck

32. A multicenter open-label randomized phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer

34. Supplementary figure 3: Cytokines and Chemokines from Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication

35. Supplementary Table ST5 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

36. Figure S3 from Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer

38. Data from Gene Silencing Associated with SWI/SNF Complex Loss during NSCLC Development

40. Supplementary Table S1.2 from Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

41. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

44. Supplementary Methods, Figure Legends from Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

45. Supplementary Figures S1- S10 from Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

46. Supplementary Figures from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

48. Supplementary Methods from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

49. Supplementary Figure Legends from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

50. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

Catalog

Books, media, physical & digital resources